American Biotech Labs® Receives 2015 Medical Innovation Award

ALPINE, UT, July 9, 2015 /CNW/ - For the fourth time in nine years, the Best of State® program's independent judges have recognized American Biotech Labs® as Utah's top company in the Medical Innovation category

American Biotech Labs, LLC (ABL), developer of a new class of products based on the company's patented nano-catalytic SilverSol Technology®, today announced that the company has won the 2015 Utah Best of State award in the category of Medical Innovation. It is the company's fourth Best of State award in the past nine years.  "We feel honored that the Best of State judges have again validated the effort we have been investing in developing new products that can help mankind," said Dr. Keith Moeller, CEO of American Biotech Labs. "There are thousands of amazing biotech companies in the state of Utah, and to be recognized as a leader in this industry we feel is a great honor and accomplishment.  This recognition highlights the reality that we are pushing new limits and engineering new innovative products that are having an important impact on mankind worldwide."

The Best of State program is a multi-faceted recognition program created to highlight excellence in business, government, education, philanthropy and the arts in Utah.  Winners for the annual Best of State event are chosen for their excellence in a wide variety of endeavors. Candidates are judged based on three criteria: achievement within their field of endeavor (50 percent); innovation or creativity in approach, techniques, methods or processes (30 percent); and contribution to improving the quality of life in Utah (20 percent). Best of State nominees are evaluated by a panel of more than 100 independent judges.

ABL products have received multiple U.S. and international patents and government approvals, including FDA OTC clearances. Recently, the U.S. Food and Drug Administration (FDA) granted ABL's ASAP OTC, Armor Gel, and ASAP Pet Shield with 510(k) medical device approvals "for the topical management of minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations." They also have claims against a number of deadly pathogens, including MRSA and VRE.  The product utilizes ABL's innovative SilverSol Technology, which has garnered over 50 patents in the U.S. and countries throughout the world.   ABL has done extensive research and studies on SilverSol Technology with some of the top universities and institutions in the world, which have documented its unique and incredible attributes and how they can be used to benefit humanity.  Information about ABL's products and technology can be found at www.ablsilver.com.

Note: Any statements released by American Biotech Labs, LLC that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance.

SOURCE American Biotech Labs, LLC

ABL at 801-756-1000 or www.ablsilver.com